These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3396489)

  • 21. Pharmacokinetics of cefodizime in elderly patients with moderate or severe renal impairment.
    Veyssier P; Devillers A; Domart Y; Fourtillan JB; Bryskier A; Procyk T
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():77-81. PubMed ID: 2074255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal function.
    Nielsen OS; Toothaker RD; Bundtzen RW; Craig WA; Welling PG; Madsen PO
    Infection; 1980; 8 Suppl 3():S 305-9. PubMed ID: 6250981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjects.
    Yost RL; Derendorf H
    Ther Drug Monit; 1986; 8(2):189-94. PubMed ID: 3726933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic profile of cefotaxime in goats.
    Atef M; Ramadan A; Afifi NA; Youssef SA
    Res Vet Sci; 1990 Jul; 49(1):34-8. PubMed ID: 2382053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients.
    Mazzei T; Novelli A; Esposito S; Fallani S; Noviello S; Cassetta MI; Conti S; Periti P
    J Chemother; 2000 Aug; 12(4):306-13. PubMed ID: 10949980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on transfer of cefotaxime into bone tissue.
    Makiyama T; Asai T
    Drugs; 1988; 35 Suppl 2():88-92. PubMed ID: 3396494
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental and clinical studies on cefodizime in pediatrics].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Yamashita F; Takajo N; Okabayashi S
    Jpn J Antibiot; 1990 Apr; 43(4):603-22. PubMed ID: 2199688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of cefodizime in the elderly following single and repeated intravenous administration of 1 g.
    Nilsen OG; Rennemo F; Rennemo R; Lenfant B
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():71-5. PubMed ID: 2074254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid.
    Beyssac E; Cardot JM; Colnet G; Sirot J; Aiache JM
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):91-102. PubMed ID: 3691581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria.
    Devlin HR; Boskovski L
    Drugs; 1988; 35 Suppl 2():45-50. PubMed ID: 3396488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-performance liquid chromatographic assay of cefotaxime, desacetylcefotaxime and ceftriaxone in rat plasma.
    Hakim L; Bourne DW; Triggs EJ
    J Chromatogr; 1988 Jan; 424(1):111-7. PubMed ID: 3366822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition kinetics and dosage regimen of cefotaxime in cross-bred male calves.
    Sharma SK; Srivastava AK; Bal MS
    Vet Res; 1995; 26(3):168-73. PubMed ID: 7795667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics of cefotaxime in cirrhotic patients with or without ascites].
    Vincent P; Colombel JF; Husson MO; Izard D; Paris JC; Leclerc H
    Presse Med; 1988 Dec; 17(44):2331-4. PubMed ID: 2974968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model].
    Rolin O; Roche G; Bouanchaud DH
    Presse Med; 1989 Oct; 18(32):1569-71. PubMed ID: 2530534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics of cefodizime in patients undergoing hemodialysis].
    Itagaki N; Hasegawa H; Sakaguchi M; Oono T; Iwamoto I; Horiuchi H; Tsujino M; Takahashi K; Imada A; Horiuchi A
    Jpn J Antibiot; 1991 Dec; 44(12):1392-6. PubMed ID: 1798074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime.
    Quintiliani R; Nightingale CH; Tilton R
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):63S-70S. PubMed ID: 6086220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure.
    el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS
    Chemotherapy; 1991; 37(2):77-85. PubMed ID: 2032473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.